DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Erstveröffentlichung

2016

Authors

Ettrich, Thomas J.

Perkhofer, Lukas

von Wichert, Goetz

Gress, Thomas M.

Michl, Patrick

et al.

Wissenschaftlicher Artikel

Published in

BMC Cancer ; 16 (2016). - Art.-Nr. 21. - ISSN 1471-2407

Link to publication

https://dx.doi.org/10.1186/s12885-016-2052-4

Faculties

Medizinische Fakultät

Institutions

UKU. Klinik für Innere Medizin I
Institut für Epidemiologie und Medizinische Biometrie

Subject headings

[Free subject headings]: Pancreatic cancer | Advanced disease | Second line therapy | cell lung-cancer | 2nd-line therapy | nab-paclitaxel | folinic acid | gemcitabine | chemotherapy | irinotecan | folfirinox | statistics | survival
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record